^
    Back
    Association details:
    Biomarker:ITM2A overexpression
    Cancer:Cervical Cancer
    Drug:cisplatin (DNA synthesis inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: D – Preclinical
    Source:
    Bioengineered
    Title:

    Integral membrane protein 2A enhances sensitivity to chemotherapy via notch signaling pathway in cervical cancer

    Published date:
    12/07/2021
    Excerpt:
    Overexpression of ITM2A increases the cisplatin sensitivity of cervical cancer cells.
    DOI:
    https://doi.org/10.1080/21655979.2021.2001218